Literature DB >> 23947352

The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.

Michael E Wortzman1, Derek L Clouthier, Ann J McPherson, Gloria H Y Lin, Tania H Watts.   

Abstract

Immunity to viruses must be tightly controlled to avoid pathology. Receptors and ligands of the tumor necrosis factor (TNF) family play important roles in controlling lymphocyte activation and survival during an immune response. The role of specific TNF receptor (TNFR) family members in antiviral immunity depends on the stage of the immune response and can vary with the virus type and its virulence. Here, we focus on five members of the TNFR family that are prominently expressed on CD8(+) T cells during viral infections, namely, 4-1BB (CD137), CD27, OX40 (CD134), GITR, and TNFR2. 4-1BB, CD27, OX40, and GITR have primarily prosurvival roles for CD8(+) T cells during viral infection, although under some circumstances 4-1BB, GITR, or CD27 signals can limit immunity. Although TNFR2 can be costimulatory under some circumstances, its main role in CD8(+) T-cell responses during viral infection appears to be in contraction of the response. Several TNF family ligands are being explored as adjuvants for viral vaccines, and agonistic antibodies to TNFR family members are being investigated for immunotherapy of chronic viral infection alone and in combination with checkpoint blockade. Such therapies will require thorough and specific optimization to avoid pathology induced by hyperstimulation of these pathways.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  4-1BB; CD27; CD70; GITR; OX40; TNF; TNFR2; acute; chronic; viral infection

Mesh:

Substances:

Year:  2013        PMID: 23947352     DOI: 10.1111/imr.12086

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  41 in total

Review 1.  Roles of TRAF3 in T cells: many surprises.

Authors:  Zuoan Yi; Alicia M Wallis; Gail A Bishop
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.

Authors:  Paurvi Shinde; Wenhai Liu; Antoine Ménoret; Andrew D Luster; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2017-04-21       Impact factor: 4.962

3.  Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.

Authors:  Bettina Weigelin; Elixabet Bolaños; Alvaro Teijeira; Ivan Martinez-Forero; Sara Labiano; Arantza Azpilikueta; Aizea Morales-Kastresana; José I Quetglas; Esther Wagena; Alfonso Rodríguez Sánchez-Paulete; Lieping Chen; Peter Friedl; Ignacio Melero
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-01       Impact factor: 11.205

Review 4.  TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

5.  The TNF Superfamily Molecule LIGHT Promotes the Generation of Circulating and Lung-Resident Memory CD8 T Cells following an Acute Respiratory Virus Infection.

Authors:  Pritesh Desai; Vikas Tahiliani; Tarun E Hutchinson; Farhad Dastmalchi; Jessica Stanfield; Georges Abboud; Paul G Thomas; Carl F Ware; Jianxun Song; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2018-03-07       Impact factor: 5.422

6.  Effects of tumor necrosis factor on viral replication and pulmonary inflammation during acute mouse adenovirus type 1 respiratory infection.

Authors:  Krittika Pant; Adithya Chandrasekaran; Christine J Chang; Aditya Vageesh; Alexandra J Popkov; Jason B Weinberg
Journal:  Virology       Date:  2020-05-23       Impact factor: 3.616

7.  The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137+ FOXP3+ Regulatory CD4 T Cells.

Authors:  Bardees M Foda; Ashley E Ciecko; David V Serreze; William M Ridgway; Aron M Geurts; Yi-Guang Chen
Journal:  J Immunol       Date:  2020-04-15       Impact factor: 5.422

Review 8.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

Review 9.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.

Authors:  Sachin Gupta; James M Termini; Saravana Kanagavelu; Geoffrey W Stone
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.